Genentech asking FDA for accelerated approval for drug to treat early-stage HER-2 breast cancer

Madely Health Headlines Commentary for September 11, 2013

Source:

FDA backs accelerated approval for drug to treat early-stage breast cancer

CORRECTION: In the interview I state that the drug is not approved for use. It is indeed approved for the treatment of late-stage aggressive HER-2 breast cancer.

Bitnami